Nutritional status in oncological patients may differ according to several modifiable and non-
modifiable factors. Knowledge of the epidemiology of malnutrition/cachexia/sarcopenia may …

Lung cancer remains the leading cause of cancer‐related death worldwide. Affected
patients frequently experience debilitating disease‐related symptoms, including dyspnea …

Sarcopenia, which is characterized by a decrease in muscle quantity or quality, is commonly
observed in patients with cancer. Recent research has reported contradictory results on the …

Purpose The metabolic changes associated with cachexia–sarcopenia syndrome might
down-regulate antitumor immunity. We hypothesized that this syndrome reduces efficiency …

Sarcopenia represents one of the hallmarks of all chronic diseases, including cancer, and
was already investigated as a prognostic marker in the pre-immunotherapy era. Sarcopenia …

Introduction Association of high body mass index (BMI) with longer survival has been
reported in patients on immune checkpoint inhibitors (ICIs), but results are inconsistent. This …

Objectives: Body mass index (BMI) is reported to be associated with the efficacy of immune
checkpoint inhibitors (ICIs) in solid tumors such as melanomas. However, it remains unclear …

Background The effect of sarcopenia on the clinical outcomes of patients with malignant
neoplasms receiving immune checkpoint inhibitors (ICIs) is unclear. The aim of this study …

Lung cancer is the most common cause of cancer death and is associated with malnutrition
and sarcopenia. The detection of sarcopenia and conduction of simple body composition …

Simple Summary Immune checkpoint inhibitor (ICI)-based immunotherapy has dramatically
improved the survival of patients with advanced non-small cell lung cancer (NSCLC); …